✦ LIBER ✦

Five-year outcomes after neoadjuvant chemotherapy and conformal radiotherapy in patients with high-risk localized prostate cancer

✍ Scribed by Charles J Ryan; Michael J Zelefsky; Glenn Heller; Kevin Regan; Steven A Leibel; Howard I Scher; William Kevin Kelly

Book ID: 116944234
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 105 KB
Volume: 64
Category: Article
ISSN: 0090-4295
DOI: 10.1016/j.urology.2004.03.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

37 oral Comparison of 5-year outcomes be

37 oral Comparison of 5-year outcomes between conformal LDR brachytherapy and high dose IMRT for patients with clinically localized prostate cancer

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 121 KB

106 oral Outcome and quality of life aft

106 oral Outcome and quality of life after HDR brachytherapy in patients with high-risk localized prostate cancer

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 125 KB

227 ADJUVANT RADIOTHERAPY AFTER RADICAL

227 ADJUVANT RADIOTHERAPY AFTER RADICAL PROSTATECTOMY IN PATIENTS WITH PATHOLOGICALLY HIGH RISK PROSTATE CANCER: 10-YEAR FOLLOW-UP RESULTS

✍ H. Van Poppel; M. Bolla; B. Tombal; K. Vekemans; L. Da Pozzo; Th.M. De Reijke; A 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 177 KB

Long-term outcomes after treatment with

Long-term outcomes after treatment with brachytherapy and supplemental conformal radiation for prostate cancer patients having intermediate and high-risk features

✍ Michael Dattoli; Kent Wallner; Lawrence True; Jennifer Cash; Richard Sorace 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 236 KB 👁 1 views

## Abstract ## BACKGROUND. This study summarizes long‐term outcomes from treatment of prostate cancer with increased risk of extracapsular cancer extension (ECE) using brachytherapy‐based treatment. ## METHODS. A total of 282 consecutive patients were treated from 1992–1996 by 1 author (M.D.). T

Phase 2 study of neoadjuvant docetaxel p

Phase 2 study of neoadjuvant docetaxel plus bevacizumab in patients with high-risk localized prostate cancer : A Prostate Cancer Clinical Trials Consortium trial

✍ Robert W. Ross; Matthew D. Galsky; Phil Febbo; Marc Barry; Jerome P. Richie; Wan 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 253 KB

Toxicity and PSA outcome for patients wi

Toxicity and PSA outcome for patients with intermediate risk prostate cancer after permanent brachytherapy boost and conformal photon or fast neutron radiotherapy

✍ N.A. Kaufman; A.J. Frazier; M. Cher; M. Lutz; F. Ahmad; S. Sircus; C. Maitland; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 56 KB